Latest News
Daily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Latest News · page 7
- Investment & Finance
The Fight for Cannabis Rescheduling Is Far From Over
Last week’s rescheduling announcement came as a surprise to many, not least to us here at Business of Cannabis.
- Policy & Regulation
The US Officially Reschedules Cannabis, Partly….
After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete step toward rescheduling cannabis.
- Investment & Finance
Federal Agencies Reportedly Told to Prep for Imminent Cannabis Rescheduling Announcement
Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling from Trump’s White House.
- Industry Trends
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics.
- Events
Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level networking and the 2026 Business of Cannabis Awards Cannabis Europa, the leading B2B conference for the European cannabis industry, today announced the full programme for its 2026 London edition.
- Medical Cannabis
The Right Reforms, the Wrong Narrative: Why the Medical Cannabis Debate Is Missing Half the Picture
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the BBC, The i Paper, Private Eye, and a swathe of other national and local publications.
- Medical Cannabis
Five Years, 74 Patients: Ireland Moves Forward With Review of Its Failing Medical Cannabis Programme
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis Access Programme (MCAP) following months of parliamentary pressure.
- CBD Market
CBD Enters US Healthcare Through Medicare Pilot, But Coverage Remains Limited
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost cannabis stocks.
- Industry Trends
Germany’s Cannabis Reform Shows No Signs of Harm its Critics Predicted, Government Mandated Data Shows
On the second anniversary of Germany’s landmark Cannabis Act (CanG) coming into force, the most comprehensive data and analysis of its impact to date has been published.
- CBD Market
Has UK’s ‘Brexit Reset’ Derailed 5-Year CBD Approval Battle?
The UK CBD industry’s long and hard-fought battle to become the first in the world to receive official regulatory approval looks likely to have been in vain, as the Food Standards Agency (FSA) raises serious questions over whether the process can deliver before it is overtaken by an EU alignment initiative.
- US & Canada
‘How Does the DEA Plan to Reschedule Without a Judge?’ – Lawmaker Demands Answers on Cannabis Rescheduling Chaos
The White House’s commitment to push through rescheduling has been challenged by a Democratic Senator, who has demanded answers on the administration’s radio silence.
- Data & Analysis
Stable Consumption, Falling Arrests: Germany’s Cannabis Landscape 2-Years On
Next week will mark the second anniversary of the implementation of Germany’s landmark Cannabis Act (CanG), which came into force on April 01, 2024.
